Yuan-Soon Ho

Personal profile

Education

1994 Ph.D., Department of Biochemical Science Technology, National Taiwan University
1990 M.S., Department of Biochemical Science Technology, National Taiwan University
1989 M.D., Medical Laboratory Science and Biotechnology, Taipei Medical University

Experience

2018.12- Professor, Department of Medical Laboratory Science and Biotechnology, Taipei Medical University
2015.02-2018.11 Professor, Graduate Institute of Medical Sciences, Taipei Medical University, Taiwan
2011.02-2015.01 Professor, Department of Medical Laboratory Science and Biotechnology, Taipei Medical University

Fingerprint Dive into the research topics where Yuan-Soon Ho is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

26 Similar Profiles

Breast Neoplasms Medicine & Life Sciences

Apoptosis Medicine & Life Sciences

Cells Chemical Compounds

Neoplasms Medicine & Life Sciences

Nicotine Medicine & Life Sciences

terbinafine Medicine & Life Sciences

Nicotinic Receptors Medicine & Life Sciences

Hepatocellular Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2010 2019

3 Active
32 Finished

組織胺甲基化轉換酵素參與國人乳癌細胞對賀癌平(HerceptinR)形成抗藥性之探討(3/3)

Ho, Y.

8/1/18 → 7/31/19

Project: A - Government Institution › b - Ministry of Science and Technology

乳癌細胞尼古丁受體表現與新穎抗體奈米藥物之臨床前試驗評估-α9尼古丁受體蛋白多形性變異致癌作用之機制探討(2/3)

Ho, Y.

8/1/18 → 7/31/19

Project: A - Government Institution › b - Ministry of Science and Technology

乳癌細胞尼古丁受體表現與新穎抗體奈米藥物之臨床前試驗評估－α9尼古丁受體蛋白多形性變異致癌作用之機制探討(2/3)(相對補助)

Ho, Y.

8/1/18 → 7/31/19

Project: A - Government Institution › f - Other (Funded by Government)

組織胺甲基化轉換酵素參與國人乳癌細胞對賀癌平(HerceptinR)形成抗藥性之探討(2/3)

Ho, Y.

8/1/17 → 7/31/18

Project: A - Government Institution › b - Ministry of Science and Technology

乳癌細胞尼古丁受體表現與新穎抗體奈米藥物之臨床前試驗評估－α9尼古丁受體蛋白多形性變異致癌作用之機制探討(1/3)(相對補助)

Ho, Y.

8/1/17 → 7/31/18

Project: A - Government Institution › f - Other (Funded by Government)

Research Output 1992 2019

4924 Citations
37 h-Index
147 Article
5 Review article
3 Conference contribution
1 Comment/debate
1 More
- 1 Patent

2 Citations (Scopus)

DNA primase polypeptide 1 (PRIM1) involves in estrogen-induced breast cancer formation through activation of the G2/M cell cycle checkpoint

Lee, W-H., Chen, L-C., Lee, C-J., Huang, C-C., Ho, Y-S., Yang, P-S., Ho, C-T., Chang, H-L., Lin, I-H., Chang, H-W., Liu, Y-R., Wu, C-H. & Tu, S-H., Feb 1 2019, In : International Journal of Cancer. 144, 3, p. 615-630 16 p.

Research output: Contribution to journal › Article

DNA Primase

G2 Phase Cell Cycle Checkpoints

Estrogens

Breast Neoplasms

Peptides

Small G protein signalling modulator 2 (SGSM2) is involved in oestrogen receptor-positive breast cancer metastasis through enhancement of migratory cell adhesion via interaction with E-cadherin

Lin, J. H., Lee, W. J., Wu, H. C., Wu, C. H., Chen, L. C., Huang, C. C., Chang, H. L., Cheng, T. C., Chang, H. W., Ho, C. T., Tu, S. H. & Ho, Y. S., Jan 1 2019, In : Cell Adhesion and Migration.

Research output: Contribution to journal › Article

Monomeric GTP-Binding Proteins

Cadherins

Cell Adhesion

Estrogen Receptors

Breast Neoplasms